Coloplast A/S (OTCMKTS:CLPBY) Announces Earnings Results, Misses Estimates By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) announced its quarterly earnings results on Tuesday. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01), Zacks reports. Coloplast A/S had a return on equity of 30.19% and a net margin of 18.69%.

Coloplast A/S Price Performance

Shares of Coloplast A/S stock opened at $11.29 on Tuesday. The firm’s 50 day moving average is $11.48 and its 200 day moving average is $12.58. Coloplast A/S has a 1 year low of $10.63 and a 1 year high of $14.34. The company has a quick ratio of 0.66, a current ratio of 1.02 and a debt-to-equity ratio of 0.92.

Coloplast A/S Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Monday, December 9th were paid a dividend of $0.2435 per share. This is an increase from Coloplast A/S’s previous dividend of $0.05. The ex-dividend date was Monday, December 9th. Coloplast A/S’s payout ratio is presently 93.94%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CLPBY. UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th. Hsbc Global Res raised Coloplast A/S from a “moderate sell” rating to a “hold” rating in a report on Monday, November 18th. Finally, Sanford C. Bernstein raised Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.